Ventricular Assist Devices: What Intensive Care Unit Nurses Need to Know about Postoperative Management
This article focuses on the physiological basis for postoperative nursing management strategies and the most important complications of which critical care nurses need to be aware.
Acquired von Willebrand Syndrome in Patients with Extracorporeal Life Support (ECLS)
Bleeding episodes are a typical complication in patients with ECLS.
Should Women Receive Left Ventricular Assist Device Support?: Findings from INTERMACS
Small studies have reported women to have worse outcomes and more adverse events after implantation of mechanical circulatory support device compared with men.
Incidence and Management of Gastrointestinal Bleeding with Continuous Flow Assist Devices
Continuous flow left ventricular assist devices (CF-LVADs) have emerged as the standard of care for patients in advanced heart failure (HF) requiring long-term mechanical circulatory support. Gastrointestinal (GI) bleeding has been frequently reported within this population.
Bivalirudin and Post-Cardiotomy ECMO: A Word of Caution
Bivalirudin has been proposed as the sole anticoagulant in patients under extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass.
Cerebral and Lower Limb Near-Infrared Spectroscopy in Adults on Extracorporeal Membrane Oxygenation
Percutaneous femoral venoarterial (VA) or jugular venovenous (VV) extracorporeal membrane oxygenation (ECMO) can result in delivery of hypoxic blood to the brain, coronaries, and upper extremities
Long-term Mechanical Circulatory Support (Destination Therapy): On Track to Compete with Heart Transplantation?
Average 2-year survival after cardiac transplantation is approximately 80%.
Mechanical Circulatory Support for Cardiogenic Shock
In this review, we discuss the role of each of these circulatory support devices in the management of acute cardiac failure.
Coagulation Management in Patients Undergoing Mechanical Circulatory Support
The incidence of bleeding and thrombo-embolic complications in patients undergoing mechanical circulatory support therapy remains high and is associated with bad outcomes and increased costs.
Current Status of Mechanical Circulatory Support: a Systematic Review
This paper outlines the current status of mechanical circulatory support.
Blood Trauma Testing of CentriMag and RotaFlow Centrifugal Flow Devices: A Pilot Study
In this feasibility study, the blood trauma performance of the RotaFlow was similar or better than the CentriMag device under clinically equivalent, worst-case test conditions. The RotaFlow device may be a more cost-effective alternative to the CentriMag.
Device Thrombogenicity Emulation: A Novel Method for Optimizing Mechanical Circulatory Support Device Thromboresistance
To address the unmet need for enhancing the thromboresistance of these devices to extend their long term use, we developed a universal predictive methodology entitled Device Thrombogenicity Emulation (DTE) that facilitates optimizing the thrombogenic performance of any MCS device--ideally to a level that may obviate the need for mandatory anticoagulation.